In the bone marrow niche, NG2+/Nestin+ mesenchymal stem cells (MSCs) promote breast cancer DTC dormancy through TGFβ2 and BMP7, and depleting MSCs or the knockout of TGFβ2 in MSCs reactivates dormant cells [42]. The gene discussed is TGFB2; the disease is breast carcinoma.